Literature DB >> 1324233

Short sequence in L1 region of human papillomaviruses correlates with clinical pictures and grouping by cross-hybridization.

A Iwamoto1, H Yoshikawa, K Kitagawa, H Igarashi, T Kawana, H Yoshikura.   

Abstract

A consensus primer-mediated polymerase chain reaction devised to amplify a short sequence in L1 region (L1-PCR) efficiently detected genital human papillomaviruses (HPVs) in clinical materials. Nucleotide sequencing of the amplified fragment showed that L1-PCR is also applicable to hitherto unsequenced HPVs. By comparing the amplified 210 nucleotides HPVs were classified into six groups, which are consistent with clinical pictures and a grouping based on cross-hybridization under the stringent condition.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1324233      PMCID： PMC5918827          DOI： 10.1111/j.1349-7006.1992.tb00107.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN： 0910-5050


  25 in total

1.  Plurality of genital human papillomaviruses: characterization of two new types with distinct biological properties.

Authors:  S Beaudenon; D Kremsdorf; S Obalek; S Jablonska; G Pehau-Arnaudet; O Croissant; G Orth
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

2.  Amplification and typing of multiple cervical cancer-associated human papillomavirus DNAs using a single pair of primers.

Authors:  H Yoshikawa; T Kawana; K Kitagawa; M Mizuno; H Yoshikura; A Iwamoto
Journal:  Int J Cancer       Date:  1990-05-15       Impact factor: 7.396

Review 3.  Heterogeneity of the human papillomavirus group.

Authors:  E M de Villiers
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products.

Authors:  S T Cole; O Danos
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

5.  Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix.

Authors:  A T Lorincz; W D Lancaster; G F Temple
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

6.  A novel type of human papillomavirus associated with genital neoplasias.

Authors:  S Beaudenon; D Kremsdorf; O Croissant; S Jablonska; S Wain-Hobson; G Orth
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

7.  Molecular cloning of a novel human papillomarvirus (type 58) from an invasive cervical carcinoma.

Authors:  T Matsukura; M Sugase
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

8.  Genome organization and nucleotide sequence of human papillomavirus type 39.

Authors:  C Volpers; R E Streeck
Journal:  Virology       Date:  1991-03       Impact factor: 3.616

9.  Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from Upper-volta.

Authors:  H Pfister; F Nürnberger; L Gissmann; H zur Hausen
Journal:  Int J Cancer       Date:  1981-05-15       Impact factor: 7.396

10.  Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers.

Authors:  H Yoshikawa; T Kawana; K Kitagawa; M Mizuno; H Yoshikura; A Iwamoto
Journal:  Jpn J Cancer Res       Date:  1991-05
View more
  3 in total

1.  Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39.

Authors:  M Longuet; S Beaudenon; G Orth
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

2.  Human papillomavirus type 70 genome cloned from overlapping PCR products: complete nucleotide sequence and genomic organization.

Authors:  O Forslund; B G Hansson
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

3.  Serum antibody against unfused recombinant E7 protein of human papillomavirus type 16 in cervical cancer patients.

Authors:  T Fujii; Y Matsushima; M Yajima; T Sugimura; M Terada
Journal:  Jpn J Cancer Res       Date:  1995-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.